Author： Stark Renee
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.24, Iss.8, 2006-01, pp. : 797-814
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inflammatory bowel disease: not all costs are equal in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. :
Access to resources
Recommend
Costs of inflammatory bowel disease in the US substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Inflammatory Bowel Disease in the Elderly
Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. :
Macrophages in Inflammatory Bowel Disease
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :